Skip to content
TripleID logo

Research

Publications

The two KET reviews describe the proposed framework. The foundational studies below document earlier findings by our investigators and collaborators.

Keystone Epitope Theory

The two reviews that describe the proposed framework. Both are open access.

  1. Peer-reviewed review

    Keystone Epitope Theory: Implications for Hypersensitivity, Autoimmunity, and Transplantation

    Mallal S, Asiaee A, Phillips E (2026). Pathog Immun 11(2):16–38

    Sets out Keystone Epitope Theory and its proposed implications for drug hypersensitivity, autoimmunity and transplantation.

    doi:10.20411/pai.v11i2.1016

  2. Peer-reviewed review

    Keystone Epitope Theory: An Ecological Perspective on RNA Viruses, Tumor Immunoediting, and Vaccine Design

    Mallal S, Asiaee A (2026). Pathog Immun 11(2):39–65

    Applies the framework to RNA viruses, tumor immunoediting and vaccine design.

    doi:10.20411/pai.v11i1.1011

Foundational studies

Earlier genetic, clinical, molecular and tissue-level findings by our investigators and collaborators. These studies establish components of the research history; they do not validate every KET mechanism. Some are behind a publisher paywall.

  1. Peer-reviewed study

    Association between presence of HLA-B*5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir

    Mallal S, Nolan D, Witt C et al. (2002). Lancet 359(9308):727–32

    The original HLA association with abacavir hypersensitivity.

    doi:10.1016/s0140-6736(02)07873-x

  2. Peer-reviewed study

    HLA-B*5701 screening for hypersensitivity to abacavir

    Mallal S, Phillips E, Carosi G et al. (2008). N Engl J Med 358(6):568–79

    The PREDICT-1 randomized trial that took HLA-B*57:01 screening into clinical practice.

    doi:10.1056/NEJMoa0706135

  3. Peer-reviewed study

    Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire

    Ostrov DA, Grant BJ, Pompeu YA et al. (2012). Proc Natl Acad Sci U S A 109(25):9959–64

    Structural and peptide-repertoire work showing how abacavir alters what HLA-B*57:01 presents.

    doi:10.1073/pnas.1207934109

  4. Peer-reviewed study

    Multiomic single-cell sequencing defines tissue-specific responses in Stevens-Johnson syndrome and toxic epidermal necrolysis

    Gibson A, Ram R, Gangula R et al. (2024). Nat Commun 15(1):8722

    Single-cell analysis of affected tissue in severe cutaneous adverse drug reactions.

    doi:10.1038/s41467-024-52990-3

Reported negative result

Results that bound what the current evidence supports.

  1. Peer-reviewed study, negative result

    Abacavir inhibits but does not cause self-reactivity to HLA-B*57:01-restricted EBV specific T cell receptors

    Sooda A, Rwandamuriye F, Wanjalla CN et al. (2022). Commun Biol 5(1):133

    Two HLA-B*57:01-restricted EBV-specific TCRs were tested. Abacavir inhibited their viral recognition but did not cause self-reactivity in the system tested. This is not a demonstration of the proposed viral-to-self cross-reactivity, and it does not exclude every possible receptor-target pair.

    doi:10.1038/s42003-022-03058-9

Forthcoming

Accepted or in production. No public record is available yet.

  1. In proof, not yet publicly available

    What HIV and SARS-CoV-2 have taught about biologic, cultural, and medical-scientific coevolution

    Mallal S (2027). On Human Nature, Chapter 50 (Elsevier)

    A book chapter placing the immunogenetics of two pandemics in the wider frame of biological and cultural coevolution. No public record is available yet.

A complete author bibliography for Elizabeth J. Phillips is available at NCBI, and for Simon Mallal at Google Scholar.